Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ANI acquires Teva's approved ANDA for anti-arrhythmic flecainide

Executive Summary

ANI Pharmaceuticals Inc. acquired Teva Pharmaceuticals USA Inc.'s approved ANDA for flecainide 50mg, 100mg, and 150mg tablets.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Reverse Licensing
    • Product Purchase

Related Companies